Dr Hayley Schultz (Kain) is a research associate and early-career researcher within UniSA Clinical & Health Sciences and affiliate member of the Quality Use of Medicines and Pharmacy Research Centre (QUMPRC). Her research focusses on using pharmacological principles to inform optimal medicine use. She works extensively with industry and clinicians, as well as other academics, and has specific skills in pharmacokinetic analysis, pharmacometrics, pharmacokinetic simulations and in vivo pharmacokinetic studies.
Dr Schultz is also a co-coordinator of the Heath Professionals Essentials undergraduate course, and has extensive experience in demonstrating undergraduate practicals.
Dr Schultz completed her PhD in early... Read more
About me
Dr Hayley Schultz (Kain) is a research associate and early-career researcher within UniSA Clinical & Health Sciences and affiliate member of the Quality Use of Medicines and Pharmacy Research Centre (QUMPRC). Her research focusses on using pharmacological principles to inform optimal medicine use. She works extensively with industry and clinicians, as well as other academics, and has specific skills in pharmacokinetic analysis, pharmacometrics, pharmacokinetic simulations and in vivo pharmacokinetic studies.
Dr Schultz is also a co-coordinator of the Heath Professionals Essentials undergraduate course, and has extensive experience in demonstrating undergraduate practicals.
Dr Schultz completed her PhD in early 2020. Hayley was supervised by Prof Clive Prestidge and her PhD thesis was titled, 'Supersaturated Silica-Lipid Hybrids - Overcoming the Challenges of Oral Drug Delivery'. Her research focussed on developing oral lipid-based formulations to improve the solubilisation and absorption of poorly water-soluble drugs. Her formulations have improved the oral bioavailability of these drugs, including ibuprofen and abiraterone acetate, to reduce their dose and to improve their safety. Her research gained great media attention, most noteworthy being featured on 7News. She published 5 first author articles from her PhD project, among many other collaborative works. Hayley's skills that she learnt during her PhD include formulation development, physicochemical characterisation of formulations, in vitro formulation testing (dissolution, lipolysis studies), ethics application writing and in vivo oral pharmacokinetic studies. During her PhD she was awarded many grants and prizes. Most significantly, she was awarded the Ian Davey Research Thesis Prize, which acknowledges the most outstanding research thesis by a UniSA HDR student leading to a PhD in 2020.
Hayley completed a Bachelor of Pharmaceutical Science in 2014 and Honours in 2015.
About me
| Date | Title |
|---|---|
| 20/09/2017 |
STEM takes Hayley from rural SA to global discovery, https://www.campustravel.com.au/news/industry/stem-takes-hayley-rural-sa-global-discovery |
| 01/06/2017 |
PhD student working on ‘next generation’ medication, https://www.unisa.edu.au/siteassets/unisanews/archive-pdfs/2017/unisanewsjune2017.pdf#page=27 |
About me
Doctor of Philosophy University of South Australia
Bachelor of Medical and Pharmaceutical Sciences (Honours) University of South Australia
Bachelor of Pharmaceutical Science University of South Australia
Research
Research outputs for the last seven years are shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2022 |
3
|
| 2022 |
Open access
1
1
|
| 2022 |
8
|
| 2022 |
|
| 2021 |
4
3
35
|
| 2021 |
Open access
1
1
5
|
| 2021 |
Open access
159
|
| 2020 |
Open access
3
3
2
|
| 2020 |
9
9
4
|
| 2020 |
Open access
3
3
|
| 2020 |
Open access
10
10
4
|
| 2020 |
Open access
9
9
204
|
| 2020 |
Open access
10
10
13
|
| 2020 |
Open access
30
29
8
|
| 2019 |
Open access
47
7
4
|
| 2019 |
13
13
5
|
| 2018 |
Open access
6
8
6
|
| 2018 |
32
32
4
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Bod Australia Pty Ltd. | AUSTRALIA |
| Chalmers University of Technology | SWEDEN |
| Johnson & Johnson | UNITED STATES |
| Macquarie University | AUSTRALIA |
| Medicines for Malaria Venture | SWITZERLAND |
| Oulu University | FINLAND |
| QIMR Berghofer Medical Research Institute | AUSTRALIA |
| Q-Pharm | AUSTRALIA |
| St Vincents Hospital | UNITED STATES |
| Swiss BioQuant | SWITZERLAND |
| TetraQ | AUSTRALIA |
| The University of Notre Dame Australia | AUSTRALIA |
| University of Cape Town | SOUTH AFRICA |
| University of Copenhagen | DENMARK |
| University of Hamburg | GERMANY |
| University of South Australia | AUSTRALIA |
| University of Sydney | AUSTRALIA |
| Van Giersbergen Consulting | FRANCE |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
General Council Board MemberAustralasian Pharmaceutical Science Association |
2022 |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| Developing advanced oral delivery systems for antiviral drugs | Current |
| Optimising treatment of haematological malignancies through the development of evidence-based dose individualisation strategies | Current |
| Pharmacogenomics to achieve precision dosing of fluoropyrimidines (FP) in cancer patients | Current |
